Obesity White Papers & Case Studies

  1. Everest Group Life Sciences eCOA Peak Matrix Assessment 2025 9/16/2025

    Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.

  2. Leading The Way In Patient Payments 9/16/2025

    Explore a solution that streamlines patient payments in clinical trials, focusing on three key benefits: Automated Payment Triggers, Superior Patient Experience, and Seamless Integration and Data Flow.

  3. Modernize Clinical Research With Continuous Digital Data 9/11/2025

    Modernize clinical research with a unified digital platform that collects continuous, high-precision data to provide meaningful discovery in clinical trials.

  4. Revitalizing Recruitment In A Lupus Rescue Study 9/11/2025

    Recruitment hurdles are overcome by leveraging engaged, data-sharing patient communities. See how a strategic, patient-centric approach delivered a pre-qualified clinical trial cohort quickly and efficiently.

  5. Rethinking Lab Logistics: Delivering The Complex Without Compromise 9/10/2025

    Through Home Trial Support (HTS), it is possible to carry out even the most demanding sampling protocols safely, consistently, and at scale—bringing collection and processing directly to patients.

  6. Engage The Right Participants Faster 9/8/2025

    Clinical trial recruitment doesn’t have to be slow, costly, or unpredictable. Find the right recruit strategy and digital recruit model for your study.

  7. A CRO Accelerating Bioanalysis 9/8/2025

    Move drug development into the modern era with a CRO that offers assay development and validation, bioanalytical testing, sample prep, and more.

  8. Preparing The Next Generation Of Clinical Research Professionals 9/4/2025

    Explore the live EDC platform that enabled Durham Tech to create a model for future-forward, hands-on education in clinical research.

  9. Advancing Alzheimer's Disease Therapies 9/3/2025

    By uniting scientific innovation with patient-focused execution, the next generation of alzheimer’s disease (AD) therapies has the potential to deliver a transformative impact on global health.

  10. De-Risking Early-Stage Biotech: Turning Vision Into Venture Capital 9/3/2025

    For early-stage biotech companies, transforming a scientific breakthrough into an investable asset requires more than compelling data—it requires a clear product vision.